Product Code: GVR-1-68038-381-2
Urinary Catheters Market Growth & Trends
The global urinary catheters market is expected to reach USD 8.0 billion by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from urinary tract infections (UTI) and blockages in the urethra are anticipated to boost the product demand. The advent of technologically advanced products is also expected to drive market growth. For instance, RIOCATH - a Reversal Inside Out Catheterization, developed by Riocath global in collaboration with IOCB Prague, reduces the chances of infections in the body.
The COVID-19 pandemic had a positive impact on the urinary catheters market. The National Center for Biotechnology Information (NCBI) reported in 2020 that the use of indwelling urinary catheters, as well as Central Venous Catheters (CVC), increased during the early stages of the COVID-19 pandemic, which is expected to boost the market. Moreover, several manufacturers are offering products such as coated urine catheters with temperature monitoring to ICU patients as stronger protection against secondary infections, which is expected to boost the market growth in the coming years.
Furthermore, technological advancements play a crucial role in fueling market growth. For instance, miniaturized catheters & introduction of antimicrobial catheters to reduce catheter-associated infections are expected to favor the urinary catheter market growth. In April 2020, Bactiguard launched a new urinary catheter- BIP Foley TempSensor, for patients in intensive care, surgery, and other conditions where continuous temperature monitoring is important.
Urinary Catheters Market Report Highlights
- In terms of product, the intermittent catheters segment dominated the overall market for the largest revenue share of over 57.5% in 2022. This can be attributed to the increasing number of patients suffering from various urinary disorders
- Urinary Incontinence (UI) emerged as the largest application segment and accounted for the largest revenue share of more than 37.1% in 2022, owing to the increasing prevalence of the disease. Factors such as surgery of the prostate gland, spinal cord injury, injury to the bladder nerves, blockage in the urine due to kidney stones, and blood clots in the urine can cause UI
- North America dominated the market with the highest revenue share of 34.4% in 2022, owing to a high incidence rate of chronic disorders as well as the availability of highly skilled physicians on this continent
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 Product
- 1.1.2 Application
- 1.1.3 Type
- 1.1.4 Gender
- 1.1.5 End-User
- 1.1.6 Regional Scope
- 1.1.7 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.2 Volume Price Analysis (Model 2)
- 1.6.2.1 Approach 2: Volume Price Analysis
- 1.7 List Of Secondary Sources
- 1.8 List Of Primary Sources
- 1.9 List Of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 Urinary Catheters Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 User Perspective Analysis
- 3.3.1 Consumer Behavior Analysis
- 3.3.2 Market Influencer Analysis
- 3.4 List Of Key End Users
- 3.5 Market Dynamics
- 3.5.1 Market Driver Analysis
- 3.5.1.1 Rising Prevalence Of Urologic Diseases
- 3.5.1.2 Increase In Geriatric Population
- 3.5.1.3 Increase In Demand For Homecare Services
- 3.5.2 Market Restraints Analysis
- 3.5.2.1 Growing Concerns Regarding Catheter Associated Urinary Tract Infection (Cauti)
- 3.5.2.2 Availability Of Alternatives
- 3.5.3 Market Opportunities Analysis
- 3.5.3.1 Presence Of Online Platform
- 3.5.3.2 Increase In The Initiatives To Raise Incontinence Awareness Worldwide
- 3.6 Urinary Catheters: Market Analysis Tools
- 3.6.1 Industry Analysis - Porter's
- 3.6.2 Swot Analysis, By Pest
- 3.7 Impact Of Covid-19 On Market & Post Pandemic Insights
Chapter 4 Urinary Catheters Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1 Definition And Scope
- 4.2 Product Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Global Urinary Catheters Market, By Product, 2018 To 2030
- 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 4.5.1 Intermittent Catheters
- 4.5.1.1 Intermittent Catheters Market, 2018 - 2030 (USD Million)
- 4.5.2 Foley/ Indwelling Catheters
- 4.5.2.1 Foley/ Indwelling Catheters Market, 2018 - 2030 (USD Million)
- 4.5.3 External Catheters
- 4.5.3.1 External Catheters Market, 2018 - 2030 (USD Million)
Chapter 5 Urinary Catheters Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 5.1 Definition And Scope
- 5.2 Type Market Share Analysis, 2022 & 2030
- 5.3 Segment Dashboard
- 5.4 Global Urinary Catheters Market, By Type, 2018 To 2030
- 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 5.5.1 Coated Catheters
- 5.5.1.1 Coated Catheters Market, 2018 - 2030 (USD Million)
- 5.5.2 Uncoated Catheters
- 5.5.2.1 Uncoated Catheters Market, 2018 - 2030 (USD Million)
Chapter 6 Urinary Catheters Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 6.1 Definition And Scope
- 6.2 Application Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 Global Urinary Catheters Market, By Application, 2018 To 2030
- 6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 6.6 Benign Prostate Hyperplasia & Prostate Surgeries
- 6.6.1 Benign Prostate Hyperplasia & Prostate Surgeries Market, 2018 - 2030 (USD Million)
- 6.6.2 Urinary Incontinence (Ui)
- 6.6.2.1 Urinary Incontinence Market, 2018 - 2030 (USD Million)
- 6.6.3 Spinal Cord Injury
- 6.6.3.1 Spinal Cord Injury Market, 2018 - 2030 (USD Million)
- 6.6.4 Others
- 6.6.4.1others Market, 2018 - 2030 (USD Million)
Chapter 7 Urinary Catheters Market: Segment Analysis, By Gender, 2018 - 2030 (USD Million)
- 7.1 Definition And Scope
- 7.2 Gender Market Share Analysis, 2022 & 2030
- 7.3 Segment Dashboard
- 7.4 Global Urinary Catheters Market, By Gender, 2018 To 2030
- 7.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 7.5.1 Male Catheters
- 7.5.1.1 Male Catheters Market, 2018 - 2030 (USD Million)
- 7.5.2 Female Catheters
- 7.5.2.1 Female Catheters Market, 2018 - 2030 (USD Million)
Chapter 8 Urinary Catheters Market: Segment Analysis, By End User, 2018 - 2030 (USD Million)
- 8.1 Definition And Scope
- 8.2 End-User Market Share Analysis, 2022 & 2030
- 8.3 Segment Dashboard
- 8.4 Global Urinary Catheters Market, By End-User, 2018 To 2030
- 8.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
- 8.5.1 Hospitals
- 8.5.1.1 Hospitals Market, 2018 - 2030 (USD Million)
- 8.5.2 Clinics
- 8.5.2.1 Clinics Market, 2018 - 2030 (USD Million)
- 8.5.3 Long-Term Care Facilities
- 8.5.3.1 Long-Term Care Facilities Market, 2018 - 2030 (USD Million)
- 8.5.4 Others
- 8.5.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 9 Urinary Catheters Market: Regional Market Analysis, By Product, By Application, Type, Gender, And By End User, 2018 - 2030 (USD Million)
- 9.1 Definition & Scope
- 9.2 Regional Market Share Analysis, 2022 & 2030
- 9.3 Regional Market Dashboard
- 9.4 Regional Market Snapshot
- 9.5 Market Size, & Forecasts, And Trend Analysis, 2021 To 2030
- 9.6 North America
- 9.6.1 North America Urinary Catheters Market, 2018 - 2030 (USD Million)
- 9.6.2 U.S.
- 9.6.2.1 Key Country Dynamics
- 9.6.2.2 Regulatory Framework & Reimbursement Structure
- 9.6.2.3 Competitive Scenario
- 9.6.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.6.3 Canada
- 9.6.3.1 Key Country Dynamics
- 9.6.3.2 Regulatory Framework & Reimbursement Structure
- 9.6.3.3 Competitive Scenario
- 9.6.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7 Europe
- 9.7.1 Europe Urinary Catheters Market, 2018 - 2030 (USD Million)
- 9.7.2 Uk
- 9.7.2.1 Key Country Dynamics
- 9.7.2.2 Regulatory Framework & Reimbursement Structure
- 9.7.2.3 Competitive Scenario
- 9.7.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.3 Germany
- 9.7.3.1 Key Country Dynamics
- 9.7.3.2 Regulatory Framework & Reimbursement Structure
- 9.7.3.3 Competitive Scenario
- 9.7.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.4 France
- 9.7.4.1 Key Country Dynamics
- 9.7.4.2 Regulatory Framework & Reimbursement Structure
- 9.7.4.3 Competitive Scenario
- 9.7.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.5 Italy
- 9.7.5.1 Key Country Dynamics
- 9.7.5.2 Regulatory Framework & Reimbursement Structure
- 9.7.5.3 Competitive Scenario
- 9.7.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.6 Spain
- 9.7.6.1 Key Country Dynamics
- 9.7.6.2 Regulatory Framework & Reimbursement Structure
- 9.7.6.3 Competitive Scenario
- 9.7.6.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.7 Denmark
- 9.7.7.1 Key Country Dynamics
- 9.7.7.2 Regulatory Framework & Reimbursement Structure
- 9.7.7.3 Competitive Scenario
- 9.7.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.8 Sweden
- 9.7.8.1 Key Country Dynamics
- 9.7.8.2 Regulatory Framework & Reimbursement Structure
- 9.7.8.3 Competitive Scenario
- 9.7.8.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.7.9 Norway
- 9.7.9.1 Key Country Dynamics
- 9.7.9.2 Regulatory Framework & Reimbursement Structure
- 9.7.9.3 Competitive Scenario
- 9.7.9.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.8 Asia Pacific
- 9.8.1 Asia Pacific Urinary Catheters Market, 2018 - 2030 (USD Million)
- 9.8.2 Japan
- 9.8.2.1 Key Country Dynamics
- 9.8.2.2 Regulatory Framework & Reimbursement Structure
- 9.8.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.8.3 China
- 9.8.3.1 Key Country Dynamics
- 9.8.3.2 Regulatory Framework & Reimbursement Structure
- 9.8.3.3 Competitive Scenario
- 9.8.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.8.4 India
- 9.8.4.1 Key Country Dynamics
- 9.8.4.2 Regulatory Framework & Reimbursement Structure
- 9.8.4.3 Competitive Scenario
- 9.8.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.8.5 Australia
- 9.8.5.1 Key Country Dynamics
- 9.8.5.2 Regulatory Framework & Reimbursement Structure
- 9.8.5.3 Competitive Scenario
- 9.8.5.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.8.6 South Korea
- 9.8.6.1 Key Country Dynamics
- 9.8.6.2 Regulatory Framework & Reimbursement Structure
- 9.8.6.3 Competitive Scenario
- 9.8.6.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.8.7 Thailand
- 9.8.7.1 Key Country Dynamics
- 9.8.7.2 Regulatory Framework & Reimbursement Structure
- 9.8.7.3 Competitive Scenario
- 9.8.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.9 Latin America
- 9.9.1 Latin America Urinary Catheters Market, 2018 - 2030 (USD Million)
- 9.9.2 Brazil
- 9.9.2.1 Key Country Dynamics
- 9.9.2.2 Regulatory Framework & Reimbursement Structure
- 9.9.2.3 Competitive Scenario
- 9.9.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.9.3 Mexico
- 9.9.3.1 Key Country Dynamics
- 9.9.3.2 Regulatory Framework & Reimbursement Structure
- 9.9.3.3 Competitive Scenario
- 9.9.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.9.4 Argentina
- 9.9.4.1 Key Country Dynamics
- 9.9.4.2 Regulatory Framework & Reimbursement Structure
- 9.9.4.3 Competitive Scenario
- 9.9.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.10 MEA
- 9.10.1 MEA Urinary Catheters Market, 2018 - 2030 (USD Million)
- 9.10.2 South Africa
- 9.10.2.1 Key Country Dynamics
- 9.10.2.2 Regulatory Framework & Reimbursement Structure
- 9.10.2.3 Competitive Scenario
- 9.10.2.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.10.3 Saudi Arabia
- 9.10.3.1 Key Country Dynamics
- 9.10.3.2 Regulatory Framework & Reimbursement Structure
- 9.10.3.3 Competitive Scenario
- 9.10.3.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.10.4 UAE
- 9.10.4.1 Key Country Dynamics
- 9.10.4.2 Regulatory Framework & Reimbursement Structure
- 9.10.4.3 Competitive Scenario
- 9.10.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 9.10.4 UAE
- 9.10.4.1 Key Country Dynamics
- 9.10.4.2 Regulatory Framework & Reimbursement Structure
- 9.10.4.3 Competitive Scenario
- 9.10.4.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 10 Urinary Catheters Market - Competitive Analysis
- 10.1 Recent Developments & Impact Analysis, By Key Market Participants
- 10.2 Company Categorization
- 10.2.1 Innovators
- 10.2.2 Market Leaders
- 10.3 Vendor Landscape
- 10.3.1 Key Company Market Share Analysis, 2021
- 10.3.2 Major Deals And Strategic Alliances
- 10.3.2.1 New Product Launch
- 10.3.2.2 Expansion
- 10.3.2.3 Acquistion
- 10.3.3 Market Entry Strategies
- 10.4 Company Profiles
- 10.4.1 Convatec Inc.
- 10.4.1.1 Company Overview
- 10.4.1.2 Product Benchmarking
- 10.4.1.3 Financial Performance
- 10.4.1.4 Strategic Initiatives
- 10.4.2 Medtronic Plc
- 10.4.2.1 Company Overview
- 10.4.2.2 Product Benchmarking
- 10.4.2.3 Financial Performance
- 10.4.2.4 Strategic Initiatives
- 10.4.3 Teleflex Incorporated
- 10.4.3.1 Company Overview
- 10.4.3.2 Product Benchmarking
- 10.4.3.3 Financial Performance
- 10.4.3.4 Strategic Initiatives
- 10.4.4 Coloplast
- 10.4.4.1 Company Overview
- 10.4.4.2 Financial Performance
- 10.4.4.3 Product Benchmarking
- 10.4.4.4 Strategic Initiatives
- 10.4.5 Bd (C. R. Bard)
- 10.4.5.1 Company Overview
- 10.4.5.2 Product Benchmarking
- 10.4.5.3 Financial Performance
- 10.4.5.4 Strategic Initiatives
- 10.4.6 Boston Scientific Corp.
- 10.4.6.1 Company Overview
- 10.4.6.2 Product Benchmarking
- 10.4.6.3 Financial Performance
- 10.4.6.4 Strategic Initiatives
- 10.4.7 Cook Medical
- 10.4.7.1 Company Overview
- 10.4.7.2 Product Benchmarking
- 10.4.7.3 Strategic Initiatives
- 10.4.8 B. Braun Melsungen Ag
- 10.4.8.1 Company Overview
- 10.4.8.2 Product Benchmarking
- 10.4.8.3 Financial Performance
- 10.4.8.4 Strategic Initiatives
- 10.4.9 Medline Industries, Inc.
- 10.4.10.1 Company Overview
- 10.4.10.2 Product Benchmarking
- 10.4.10.3 Financial Performance
- 10.4.10.4 Strategic Initiatives
- 10.4.10 J And M Urinary Catheters Llc
- 10.4.10.1 Company Overview
- 10.4.10.2 Product Benchmarking
- 10.4.10.3 Financial Performance
- 10.4.10.4 Strategic Initiatives